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Abstract: This article is based on a talk given at the Japanese Society for Tropical medicine Annual Meeting in
2014.
The severe febrile illness study was established in 2005. The aim of the project was to define the aetiology of
febrile disease in children admitted to a hospital in Tanzania. Challenges arose in many areas:
Study design: An initial plan to recruit only the severely ill was revised to enroll all febrile admissions leading to a
more comprehensive dataset but much increased costs. Operationally a decision was made to set up a paediatric
acute admissions unit (PAAU) in the hospital to facilitate recruitment and to provide appropriate initial care in line
with perceived ethical obligations. This had knock on effects relating to the responsibilities that were taken on but
also some unexpected positive outcomes.
Study personnel: Local research staff were sometimes called upon to make up temporary shortfalls in the hospital
staffing. Lack of staff made it impossible to recruit patients around the clock, seven days a week creating the
challenge of ensuring representative sampling.
Quality control: Studies based on clinical examination create unique quality control challenges—how to ensure
that clinical staff are examining in a systematic and reproducible way. We designed a sub-study to both explore
this and improve quality.
Summary: Setting up clinical research projects is severely resource poor settings creates many challenges
including those of an operational, technical and ethical nature. Whilst there are no ‘right answers’ an awareness of
these problems can help overcome them.
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INTRODUCTION
The work I’m going to discuss is work that I did when
I was working with the London School of Hygiene and
Tropical Medicine in Tanzania. The study I’m going to
discuss was called the severe febrile illness (SFI) study and
I’ll discuss its study design, going behind the data to
explore the challenges of implementing that study design;
looking in particular at infrastructure challenges, chal-
lenges relating to personnel, and quality control, to illus-
trate some of these difficulties. Then to discuss some of the
outcomes of the study and some of the research that we
did.
The aim of the severe febrile illness study was to
determine the treatable causes of severe febrile illness
amongst children admitted to an African rural district hos-
pital in an area where there was high malaria transmission.
Where is this study? Muheza, Tanzania, in East Africa,
near the Indian Ocean coast. It’s a lowland area with high
malaria transmission at the time of the study.
STUDY DESIGN
The design was a prospective observational study that
would run over 1 calendar year. The original plan was to
include severely ill admissions to the pediatric ward aged
between 2 months and 13 years who had a fever or a his-
tory of fever. As we began to plan the study more care-
fully, it became clear that defining severe febrile illness
was not so straightforward. Whilst there are good criteria
to define severe malaria [1, 2], for non-malarial febrile ill-
ness, it’s not so easy. We decided instead to enroll all
admissions with a fever or a history of fever regardless of
their severity, so that we could determine severity criteria
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ourselves. This of course had important implications in
that we went from anticipating recruitment of perhaps 500
or 600 to anticipating recruitment of several thousand
patients.
CHALLENGES WITH INFRASTRUCTURE
The hospital we were working in was a district hospi-
tal, rather than a university or teaching hospital. This
brought with it some challenges. In terms of the infrastruc-
ture in the hospital, children were admitted to two wards at
the time that we began the study. Clearly, if you’re aiming
to capture every admission, then having to be in two places
creates a fairly simple problem. Bed occupancy was very
high, often two or three children per bed, particularly after
the rainy season. This meant that the clinical staff were
very, very busy doing their own work. With such high
admission numbers, there were often stock-outs of essen-
tial medicines including quinine, which was the first-line
treatment for severe malaria at that time. There was also
very little oxygen available, indeed often there was no
oxygen available on the pediatric ward for weeks at a time.
Why is this relevant to doing research? Well, when
we were trying to see how the hospital worked in order to
build the study, we would often see children who were
severely ill being admitted and it was not uncommon that
because of lack of resources, because of lack of stocks,
children were dying from preventable causes. To take data
from these children without addressing their health needs
would not have been right. This was a problem that we
needed to address.
In terms of research infrastructure, this was the largest
piece of inpatient research that had been attempted at this
hospital. There had been some important outpatient
research in malaria treatments, but nothing of this scale
addressing inpatients. The hospital had a limited microbi-
ology service, and our aim was to be doing blood cultures
on all of these children. In common with most district hos-
pitals, there was little quality control of malaria micro-
scopy, so this also needed to be improved.
INFRASTRUCTURE SOLUTIONS
How did we propose to solve these problems? We set
up and built a pediatric admissions unit for the hospital.
Outside one of the paediatric wards we built a concreted
seating area with a roof, so that we had somewhere the
mothers could wait with their children before they were
seen by one of the clinical assistants.
Inside the ward, we sectioned off one end with a
wooden partition. On one side of the partition we had two
beds in which we could systematically record the examina-
tion findings in the consenting children and do a set of
simple tests (Fig. 1). All of the consenting children had
rapid tests for malaria, they were tested for HIV if their
parents gave consent, they had a blood culture performed
and had bedside tests for hemoglobin, blood lactate, and
blood glucose. Based on the clinical examination and
results of these tests, we gave them an admission diagnosis
and provided them with initial treatments, including resus-
citation where necessary.
To support the unit, we procured our own essential
medications, our own fluids and giving sets and we even
set up our own avenue for getting an oxygen supply for the
children. The laboratory also required improvement; we
procured a BacT-ALERT automated culture system for
blood cultures, a Coulter counter for full blood counts and
some other fairly simple machines that weren’t available
previously. Culture media and some reagents had to be
imported to ensure results were of the highest quality,
since previously homemade culture media had been used.
HUMAN RESOURCES CHALLENGES
Of course, a new admissions unit is no good without
staff. At the time that we started, the only paediatrician
was heavily involved in hospital management, and there
was no qualified physician on the pediatric wards. The
pediatric ward was staffed by clinical officers, a grade of
non-physician clinicians who have 2–3 years of training
before they are deployed. They are the backbone of staff in
district hospitals. There was one clinical officer for the
ward, though they were often redeployed after their morn-
ing ward round. Things were little better from the nursing
perspective, with a shortage of trained nurses on the wards.
The solution was that we had to provide research staff. On
Fig. 1. The paediatric assessment unit with the ward in the
background.
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site we had a UK-trained clinician in me and a UK-trained
microbiologist. We recruited four clinical officers, four
nurses, two assistants, and four lab staff in Tanzania.
About halfway through the study, we also recruited a
Tanzanian counterpart to me—another physician. Of
course, the staff had to be trained in certain clinical skills
and in research methods and Good Clinical Practice. Skills
in resuscitation, when you’re not able to practice it are
soon forgotten. For most of our clinical officers, deprived
of the resources and support to exercise these skills, the
knowledge and skills in resuscitation had lapsed. We had
to retrain them using roleplay and close supervision. This
included a systematic approach to recording clinical signs.
One of the most rewarding things of my time in Tanzania
was that by the time I left the staff were able to run resus-
citation of children themselves without any supervision. I
can remember towards the end of the time I was there
receiving a phone call in the office, at the hospital, saying
that I was needed on the ward. I went down to the ward
quickly expecting that they were having some difficulty
resuscitating a child that needed an intra-osseous infusion
or some such. However when I got there, there was no
child in distress, it was simply that the printer wasn’t
working! This was how they had evolved over the time.
Another issue that we had to face, because of a tem-
porary staffing crisis in the hospital itself, was that the hos-
pital came to us asking if they could borrow our staff for
clinical duties within the hospital. At this point we had
more clinical officers working in the research project than
the whole hospital had for other care. The difficulty was
that to some extent we would be compromising our
research by lending our staff to the hospital. However the
hospital and the patients certainly needed our help, so we
reduced our recruiting times a little for a period and
deployed staff to the hospital.
QUALITY CONTROL
Quality control in this environment is obviously
important and a lot of this was achieved through supervi-
sion. We also organized a system of performing replicate
measurements; one clinical officer would look at child and
describe their status, respiratory rate, chest in-drawing, and
so forth. Then another clinical officer or nurse would look
at the same child and describe the same factors. We would
analyse the concordance and we were later able to publish
our findings [3]. We did the same duplication with height
and weight, ensuring that our repeat measurements were
within acceptable margins.
In the lab, supervision of microbiology was necessary
and we had two collaborators that helped to make sure that
we were identifying bacteria correctly. One was a surveil-
lance group working in East Africa to whom we sent all of
our pneumococci and Haemophilus (NETSPEAR). The
other one was the University of Queensland in Australia
who received Gram negatives.
In microscopy again supervision was important for
quality control. Here we used a system suggested to me by
one of my Professors—a lighthearted wager with the
microscopist. I would meet the microscopist to challenge
him that I could find a malaria parasite on a film that he
had reported as negative. If a parasite was found, he had to
buy the sodas, if I failed, I had to buy them. This way, he
knew that there was going to be somebody double check-
ing his results all the time. He also learnt that he could get
a lot of sodas out of me! Of course, in any case all of the
blood slides were double read with discordant slides read
for a third time.
RESULTS AND RESEARCH OUTPUT
What did all of this achieve? Well, in terms of the eti-
ology of disease, we recruited just over 3500 children over
the course of 1 year. This was out of an estimated 6500
children that we think were hospitalized over that period—
around two-thirds. Unsurprisingly, about two-thirds of the
patients had falciparum malaria on a blood slide. About
9% had invasive bacterial disease (IBD)—either a positive
blood culture or a positive CSF sample. HIV prevalence
was low, around 4%. We had very high rates of acceptance
for HIV testing, with very few mothers who refused to
have their child tested. There was a group of about 20% or
30% where we could not find any pathogen at all [4]
(Fig. 2).
In terms of the bacteria that were isolated from blood,
the headline was high rates of Non-typhoid Salmonella
septicaemia. Almost half of the bacterial isolates that we
found were Salmonella typhimurium or Salmonella enteri-
tidis. This is in keeping with data from other centers where
there are high levels of malaria transmission [5]. The next
most common was Streptococcus pneumoniae and Haemo-
philus influenzae B. At the time of the study, there was no
vaccination program for Haemophilus influenzae B in
Tanzania. Since then the Ministry of Health has gone on to
institute a vaccination program, which is now well under-
way. The key to making the most of this microbiological
data was tying the microbiology and the clinical data
together and putting it in a context that was clinically rele-
vant. At the time the Pocket Book of Hospital Care for
Children was produced by the WHO [6]. The aim was that
this would be a reference book that could fit in the pocket
of a doctor or clinical officer working in a district hospital,
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providing them with guidance on how to treat common
conditions. The guidance provided a clinical diagnosis
based on few tests and the management plan including
antibiotic therapy. We found that in our setting, one-third
of the patients who were shown to have invasive bacterial
disease by blood culture or CSF were missed by these
guidelines. This was improved a little by the addition of
several other factors as indications for bacterial disease.
But in terms of the choice of antibiotic, the guidelines per-
formed poorly; in over half of the cases the bacteria isola-
ted were resistant to the recommended antibiotics. We
found the guidelines did not function as well as they
should have done in this setting with a lot of malaria trans-
mission [4].
Some other outputs from the study; we explored the
relationship between point-of-care blood lactate and mor-
tality. In both malaria slide-positive and slide-negative
children, high blood lactate, measured with a point of care
device, was associated with a raised case fatality and clini-
cal signs had poor sensitivity to predict hyperlactatemia
[7].
We also described the relationship between mortality
and admission blood glucose, also measured in all children
at admission. Whilst the normal cutoff for hypoglycemia is
2.5 mmol/L, there was greater mortality at levels of blood
glucose that were low, but above this threshold for hypo-
glycemia compared with children with higher blood glu-
Fig. 2. Numbers and deaths (CFR) of children infected with
P. falciparum, IBD or HIV. 
Venn diagram approximately to scale. 
* IBD consisted of 336 children with a positive blood
culture, of whom 20 also had a positive CSF culture
and an additional 5 with a pathogenic organism
isolated from CSF and a negative or contaminated
blood culture. 
† Blood cultures classified as negative included 251
(6.9%) from which contaminant organisms only were
cultured. 
Three negative HIV results were based on Capillus-
testing only (negative predictive value 99.5%, detail
not shown); all other HIV results based on at least 2
concordant test results.
cose levels [8] (Fig. 3). Paediatric admissions with blood
glucose in this range need to be studied to see if there is
anything that could be done to prevent this excess mortal-
ity.
Because we were at this site for several years, we
were able to look at malaria and non-typhoidal Salmonella
over the course of time. In a similar fashion to the studies
published from Kilifi in Kenya and also from The Gambia
[9, 10], we showed that malaria declined over the course of
these years [11]. With this decline came a big drop in non-
typhoidal Salmonella bacteraemia and hence all-cause bac-
teraemia.
Many papers have now been published involving data
from the pediatric assessment unit that we set up in 2005
for the SFI study. The unit was then involved in further
research and currently the Muheza unit has been involved
in over 25 publications relating to the management of child
health in African hospitals. The site was involved in two of
the most important recent studies. Firstly the AQUAMAT
study comparing artesunate and quinine in severe malaria,
the Muheza site provided a large number of children to the
study [12]. Then, the Fluid Expansion As Supportive Ther-
apy (FEAST) trial for treating impaired perfusion in Afri-
can children [13]. I think had we not set up the paediatric
assessment unit at the beginning, some of this work would
not have happened in that setting.
Failings; I think we have been a little bit show in pub-
lishing. I think publishing in 2013 research that was com-
pleted in 2007 is a bit slow. Also we collected a large
number of convalescent plasma samples from patients and
we have published little with that, which is a shame. We
have published little concerning HIV and severe acute
Fig. 3. Mortality risk by admission blood glucose and results
of admission blood slide for Plasmodium falciparum.
Bars represent 95% confidence intervals.
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malnutrition, though some publications may yet come
from these data.
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